Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

924 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting Polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor.
Alimova I, Pierce AM, Harris P, Donson A, Birks DK, Prince E, Balakrishnan I, Foreman NK, Kool M, Hoffman L, Venkataraman S, Vibhakar R. Alimova I, et al. Among authors: pierce am. Oncotarget. 2017 Oct 19;8(57):97290-97303. doi: 10.18632/oncotarget.21932. eCollection 2017 Nov 14. Oncotarget. 2017. PMID: 29228610 Free PMC article.
Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I, Pierce A, Danis E, Donson A, Birks DK, Griesinger A, Foreman NK, Santi M, Soucek L, Venkataraman S, Vibhakar R. Alimova I, et al. Among authors: pierce a. Int J Cancer. 2019 Apr 15;144(8):1983-1995. doi: 10.1002/ijc.31873. Epub 2019 Jan 10. Int J Cancer. 2019. PMID: 30230537
Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma.
Pierce AM, Witt DA, Donson AM, Gilani A, Sanford B, Sill M, Van Court B, Oweida A, Prince EW, Steiner J, Danis E, Dorris K, Hankinson T, Handler MH, Jones KL, Karam SD, Serkova NJ, Vibhakar R, Foreman NK, Griesinger AM. Pierce AM, et al. Neuro Oncol. 2019 Dec 17;21(12):1540-1551. doi: 10.1093/neuonc/noz116. Neuro Oncol. 2019. PMID: 31276586 Free PMC article.
Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine.
Moreira DC, Venkataraman S, Subramanian A, Desisto J, Balakrishnan I, Prince E, Pierce A, Griesinger A, Green A, Eberhardt CG, Foreman NK, Vibhakar R. Moreira DC, et al. Among authors: pierce a. J Neurooncol. 2020 May;147(3):531-545. doi: 10.1007/s11060-020-03457-0. Epub 2020 Mar 16. J Neurooncol. 2020. PMID: 32180106 Free PMC article.
Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma.
Dahl NA, Danis E, Balakrishnan I, Wang D, Pierce A, Walker FM, Gilani A, Serkova NJ, Madhavan K, Fosmire S, Green AL, Foreman NK, Venkataraman S, Vibhakar R. Dahl NA, et al. Among authors: pierce a. Cell Rep. 2020 Apr 7;31(1):107485. doi: 10.1016/j.celrep.2020.03.049. Cell Rep. 2020. PMID: 32268092 Free PMC article.
Preclinical and clinical investigation of intratumoral chemotherapy pharmacokinetics in DIPG using gemcitabine.
Green AL, Flannery P, Hankinson TC, O'Neill B, Amani V, DeSisto J, Knox A, Chatwin H, Lemma R, Hoffman LM, Mulcahy Levy J, Raybin J, Hemenway M, Gilani A, Koschmann C, Dahl N, Handler M, Pierce A, Venkataraman S, Foreman N, Vibhakar R, Wempe MF, Dorris K. Green AL, et al. Among authors: pierce a. Neurooncol Adv. 2020 Feb 24;2(1):vdaa021. doi: 10.1093/noajnl/vdaa021. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32642682 Free PMC article.
924 results